Literature DB >> 11024608

Nosocomial infections in an Iranian burn care center.

A R Lari1, R Alaghehbandan.   

Abstract

Burn patients are obviously at high risk for nosocomial infections due to the immunocompromizing effects of burn injury. Pseudomonas aeruginosa is an important life-threatening nosocomial pathogen in burn units. The aim of this study was to determine nosocomial infections in the Tohid Burn Center in Tehran, Iran. Materials of this study were samples of burn wounds and blood from 582 patients who required hospitalization during March 1996 and September 1998. Burn wound samples were taken on admission day, 3 and 7 days after admission. Frequency of culture positive on admission day, 3 and 7 days after admission were 15, 66, and 88%, respectively. Frequency of P. aeruginosa and Staphylococcus aureus on admission day were 35 and 34%, on the third day after admission 73 and 15%, and at the end of the first week of admission 87 and 9%, respectively. Frequency of blood culture positive was 36% (19/53) of which 89% were P. aeruginosa. Overall mortality rate was 18.5% (108/582). Of these patients, frequency of positive wound culture was 92% (99/108). In conclusion, our results show that P. aeruginosa is the leading cause of nosocomial infections in our burn center. It is also necessary to introduce urgent measures for restriction of the spread of P. aeruginosa infections in our burn center.

Entities:  

Mesh:

Year:  2000        PMID: 11024608     DOI: 10.1016/s0305-4179(00)00048-6

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  24 in total

1.  Pattern of bacterial invasion in burn patients at the pakistan institute of medical sciences, islamabad.

Authors:  M Ahmad; S Shahid Hussain; M Ibrahim Khan; S A Malik
Journal:  Ann Burns Fire Disasters       Date:  2006-03-31

2.  Barriers to Surgical Care and Health Outcomes: A Prospective Study on the Relation Between Wealth, Sex, and Postoperative Complications in the Republic of Congo.

Authors:  Brian M Lin; Michelle White; Ana Glover; Greta Peterson Wamah; Davi L Trotti; Kirstie Randall; Blake C Alkire; Mack L Cheney; Gary Parker; Mark G Shrime
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

3.  KPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran.

Authors:  L Azimi; A Rastegar Lari; R Alaghehbandan; F Alinejad; M Mohammadpoor; M Rahbar
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

4. 

Authors:  A Krir; S Dhraief; A A Messadi; L Thabet
Journal:  Ann Burns Fire Disasters       Date:  2019-09-30

5.  Nosocomial infections among burn patients in Teheran, Iran: a decade later.

Authors:  R Alaghehbandan; L Azimi; A Rastegar Lari
Journal:  Ann Burns Fire Disasters       Date:  2012-03-31

Review 6.  The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.

Authors:  James A Driscoll; Steven L Brody; Marin H Kollef
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  The bacteriological profile of the burned patients in the center of burns in CHU Mohamed VI Marrakech (about 123 cases).

Authors:  Yassine Benchamkha; Ouafaa Dhaidah; Adil Dahazze; Quaboul Meriem; Moulay Driss Elamrani; Salwa Ettalbi
Journal:  Int J Burns Trauma       Date:  2017-10-25

8.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Epidemiology of pneumonia in a burn care unit: the influence of inhalation trauma on pneumonia and of pneumonia on burn mortality.

Authors:  E Liodaki; K Kalousis; K L Mauss; T Kisch; P Mailaender; F Stang
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

10.  Infection control in severely burned patients.

Authors:  Yusuf Kenan Coban
Journal:  World J Crit Care Med       Date:  2012-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.